PT2726507T - Anticorpos contra antigéneos celulares especificos da próstata e uso dos mesmos - Google Patents
Anticorpos contra antigéneos celulares especificos da próstata e uso dos mesmosInfo
- Publication number
- PT2726507T PT2726507T PT12729996T PT12729996T PT2726507T PT 2726507 T PT2726507 T PT 2726507T PT 12729996 T PT12729996 T PT 12729996T PT 12729996 T PT12729996 T PT 12729996T PT 2726507 T PT2726507 T PT 2726507T
- Authority
- PT
- Portugal
- Prior art keywords
- stem cell
- antibodies against
- cell antigen
- specific stem
- against prostate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011118022.6A DE102011118022B4 (de) | 2011-06-30 | 2011-06-30 | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2726507T true PT2726507T (pt) | 2019-02-26 |
Family
ID=46384405
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT12729996T PT2726507T (pt) | 2011-06-30 | 2012-06-29 | Anticorpos contra antigéneos celulares especificos da próstata e uso dos mesmos |
Country Status (17)
Country | Link |
---|---|
US (1) | US9200078B2 (ja) |
EP (2) | EP3505536A1 (ja) |
JP (4) | JP2014528696A (ja) |
AU (1) | AU2012277784B2 (ja) |
CY (1) | CY1121249T1 (ja) |
DE (1) | DE102011118022B4 (ja) |
DK (1) | DK2726507T3 (ja) |
ES (1) | ES2711978T3 (ja) |
HR (1) | HRP20190289T1 (ja) |
HU (1) | HUE042008T2 (ja) |
LT (1) | LT2726507T (ja) |
PL (1) | PL2726507T3 (ja) |
PT (1) | PT2726507T (ja) |
RS (1) | RS58448B1 (ja) |
SI (1) | SI2726507T1 (ja) |
TR (1) | TR201901991T4 (ja) |
WO (1) | WO2013001065A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102011118022B4 (de) * | 2011-06-30 | 2018-01-18 | Gemoab Monoclonals Gmbh | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
EP2990416B1 (en) | 2014-08-29 | 2018-06-20 | GEMoaB Monoclonals GmbH | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
AU2018219887A1 (en) | 2017-02-08 | 2019-08-22 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins for activation of natural killer cells and therapeutic uses thereof to treat cancer |
EP4273258A3 (en) | 2017-02-20 | 2024-01-17 | Dragonfly Therapeutics, Inc. | Proteins binding her2, nkg2d and cd16 |
WO2019066093A1 (ko) * | 2017-09-26 | 2019-04-04 | 주식회사 와이바이오로직스 | Scf 특이적 항체 |
CA3237846A1 (en) | 2018-02-08 | 2019-08-15 | Dragonfly Therapeutics, Inc. | Antibody variable domains targeting the nkg2d receptor |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541212B2 (en) * | 1997-03-10 | 2003-04-01 | The Regents Of The University Of California | Methods for detecting prostate stem cell antigen protein |
CA2281877C (en) * | 1997-03-10 | 2010-01-05 | The Regents Of The University Of California | Psca: prostate stem cell antigen |
KR100490077B1 (ko) | 1999-10-29 | 2005-05-17 | 제넨테크, 인크. | 항-전립선 줄기세포 항원 (psca) 항체 조성물 및 그의사용 방법 |
WO2005040220A1 (en) * | 2003-10-16 | 2005-05-06 | Micromet Ag | Multispecific deimmunized cd3-binders |
WO2005118864A2 (en) * | 2004-05-28 | 2005-12-15 | Agensys, Inc. | Antibodies and related molecules that bind to psca proteins |
US8940298B2 (en) | 2007-09-04 | 2015-01-27 | The Regents Of The University Of California | High affinity anti-prostate stem cell antigen (PSCA) antibodies for cancer targeting and detection |
CA2738545A1 (en) * | 2008-10-01 | 2010-04-08 | Micromet Ag | Cross-species-specific pscaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-1rxcd3 or fapalpha xcd3 bispecific single chain antibody |
US20110142811A1 (en) * | 2009-12-16 | 2011-06-16 | Deutsches Krebsforschungszentrum | Measles virus for the elimination of unwanted cell populations |
DE102011118022B4 (de) * | 2011-06-30 | 2018-01-18 | Gemoab Monoclonals Gmbh | Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung |
-
2011
- 2011-06-30 DE DE102011118022.6A patent/DE102011118022B4/de not_active Expired - Fee Related
-
2012
- 2012-06-29 PL PL12729996T patent/PL2726507T3/pl unknown
- 2012-06-29 HU HUE12729996A patent/HUE042008T2/hu unknown
- 2012-06-29 JP JP2014517736A patent/JP2014528696A/ja active Pending
- 2012-06-29 SI SI201231523T patent/SI2726507T1/sl unknown
- 2012-06-29 DK DK12729996.4T patent/DK2726507T3/en active
- 2012-06-29 PT PT12729996T patent/PT2726507T/pt unknown
- 2012-06-29 AU AU2012277784A patent/AU2012277784B2/en active Active
- 2012-06-29 US US14/129,933 patent/US9200078B2/en active Active
- 2012-06-29 ES ES12729996T patent/ES2711978T3/es active Active
- 2012-06-29 WO PCT/EP2012/062716 patent/WO2013001065A1/de active Application Filing
- 2012-06-29 TR TR2019/01991T patent/TR201901991T4/tr unknown
- 2012-06-29 EP EP18207370.0A patent/EP3505536A1/de active Pending
- 2012-06-29 EP EP12729996.4A patent/EP2726507B1/de active Active
- 2012-06-29 RS RS20190218A patent/RS58448B1/sr unknown
- 2012-06-29 LT LTEP12729996.4T patent/LT2726507T/lt unknown
-
2017
- 2017-01-12 JP JP2017002983A patent/JP6549622B2/ja active Active
-
2019
- 2019-02-11 CY CY20191100176T patent/CY1121249T1/el unknown
- 2019-02-13 HR HRP20190289TT patent/HRP20190289T1/hr unknown
- 2019-06-26 JP JP2019117977A patent/JP6886491B2/ja active Active
-
2021
- 2021-05-13 JP JP2021081553A patent/JP7341185B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
PL2726507T3 (pl) | 2019-06-28 |
JP2017104113A (ja) | 2017-06-15 |
HRP20190289T1 (hr) | 2019-05-03 |
CY1121249T1 (el) | 2020-05-29 |
DE102011118022A1 (de) | 2013-01-03 |
DE102011118022B4 (de) | 2018-01-18 |
AU2012277784A1 (en) | 2014-02-06 |
JP2021121201A (ja) | 2021-08-26 |
JP6549622B2 (ja) | 2019-07-24 |
DK2726507T3 (en) | 2019-03-11 |
LT2726507T (lt) | 2019-04-10 |
US9200078B2 (en) | 2015-12-01 |
ES2711978T3 (es) | 2019-05-08 |
AU2012277784B2 (en) | 2015-08-20 |
RS58448B1 (sr) | 2019-04-30 |
EP2726507A1 (de) | 2014-05-07 |
TR201901991T4 (tr) | 2019-03-21 |
WO2013001065A1 (de) | 2013-01-03 |
US20140134155A1 (en) | 2014-05-15 |
JP7341185B2 (ja) | 2023-09-08 |
EP2726507B1 (de) | 2018-11-21 |
JP2014528696A (ja) | 2014-10-30 |
HUE042008T2 (hu) | 2019-06-28 |
SI2726507T1 (sl) | 2019-05-31 |
EP3505536A1 (de) | 2019-07-03 |
JP6886491B2 (ja) | 2021-06-16 |
JP2019193652A (ja) | 2019-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2100034I1 (hu) | ANGPTL3-ellenes antitestek és alkalmazásaik | |
IL288203B (en) | Meditops and Meditop binding antibodies and their use | |
IL251697A0 (en) | Antibodies against 3erbb and their uses | |
HK1243344A1 (zh) | 抗體製劑和方法 | |
IL232399A0 (en) | Anti-2fgfr antibodies and their use | |
EP2682475A4 (en) | ANTIBODIES AND ANTIGENS FOR THE DETECTION OF TUMOR-INITIATIVE CELLS AND USE THEREOF | |
HRP20190289T1 (hr) | Protutijela protiv antigena specifičnog za matične stanice prostate i njihova upotreba | |
HK1199842A1 (en) | Anti-siglec-15 antibodies and uses thereof -15 | |
EP2620449A4 (en) | EPIDINATED ANTIBODIES AGAINST B2 AND THE USE THEREOF | |
EP2785738A4 (en) | ANTI-NPY ANTI-PYY ANTIBODIES AND USES THEREOF | |
EP2739306A4 (en) | OPTIMIZED ANTIGENS OF PNEUMOCYSTOSIS AND THEIR USE | |
EP2578682A4 (en) | ANTIBODIES AND ITS USE |